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ICHAbstract Simple, precise, and accurate UV-Spectrophotometric and high-performance thin-layer
chromatography (HPTLC) methods for the simultaneous determination of Nitazoxanide and
Oﬂoxacin in pharmaceutical preparations have been developed and validated. The method was
developed using aluminum plates pre-coated with silica gel 60 F254 HPTLC plates as a stationary
phase with toluene:chloroform:carbon tetra chloride:toluene:glacial acetic acid solutions in the pro-
portion of (10:5:3:0.5 v/v/v/v) as mobile phase. Densitometric quantiﬁcation was performed at
241 nm. Well-resolved bands were obtained with RF values 0.36, 0.57 and 0.63 for Rosiglitazone
maleate, Nitazoxanide, and Oﬂoxacin, respectively. Rosiglitazone maleate was used as an internal
standard. The calibration curves were linear within the concentration range of 5–25 lg/ml for each
drug. Two simple spectrophotometric methods have been developed for simultaneous estimation of
Nitazoxanide, and Oﬂoxacin from tablet dosage form. The ﬁrst method, simultaneous equation
method, involves the measurement of absorbances at two wavelengths 221.8 nm (kmax of Nitazox-
anide) and 244.3 nm (kmax of Oﬂoxacin), and the second method is First order derivative spectros-
copy, wavelengths selected for quantitation were 263.6 nm for Nitazoxanide and 269.2 nm for
Oﬂoxacin. The proposed method gave good validation results and the statistical analysis performed
proved that the method is precise, accurate and reproducible, and hence can be employed for rou-
tine analysis of Nitazoxanide and Oﬂoxacin in bulk and commercial formulations.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Oﬂoxacin (OFL) is chemically 9-ﬂuoro-2,3-dihydro-3-methyl-
10-(4-methyl-1-piperazinyl)-7-Oxo-7H-pyrido (1,2,3-di)-1,4-
benzoxazine carboxylic acid. It is a ﬂuoroquinolone derivative.
It is used mainly as an antibacterial. It is ofﬁcial in the United
Figure 1 Overlain spectra Nitazoxanide and Oﬂoxacin.
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spectrophotometric, HPLC, RP-HPLC, and HPTLC (Rane
et al., 2008; Kasture et al., 2004; Gopu et al., 2007; Kraas
and Hirrle, 1986; Gandhimathi et al., 2006) methods are avail-
able for the determination of Oﬂoxacin from pharmaceutical
preparations and biological formulation. Nitazoxanide (NT),
N-(5-nitro-2-thiazolyl) salicylamide acetate (O’Neil, 2001;
Reynolds, 2002) is a Nitrothiazole derivative. Its chemical
structure is related to metronidazole. It is a broad spectrum
antiprotozoal. Nitazoxanide is an antiamebic and anthelmintic
agent. It is indicated for amebiasis, helminthiasis, giardiasis,
fascioliasis, trichomoniasis and cryptosporidiosis, including
those with AIDS or HIV infections (Yoshimasa et al., 1996;
Cavier, 1978). Literature survey reveals that, spectrophotomet-
ric and RP-HPLC (Kapse et al., 2006; Narayana et al., 2006)
methods are available for the estimation of Nitazoxanide in
single dosage form. A survey of the literature reveals of these
combination that a variety of spectrophotometric and chro-
matographic methods (Singh et al., 2011; Game and Sakarkar,
2011; Lalitha et al., 2009; Mahaparale et al., 2009). An Oﬂox-
acin and Nitazoxanide combination is indicated to have
antibacterial and antiprotozoal activities. The combination
of Nitazoxanide and Oﬂoxacin is antiparasitic and antibacte-
rial which is effective against a wide variety of protozoa, hel-
minthes and Gram-negative organisms. Oral bioavailability
is good and well tolerated, with mild gastrointestinal side ef-
fects. Used in Giardia intestinal is induced diarrhea in patients
(Guerrant et al., 2005). A combination of 200 mg of oﬂoxacin
and 500 mg of Nitazoxanide is available commercially as
tablets (Nitazete-O). The aim of this paper was to explore
the possibility of techniques of simultaneous estimation using
UV spectrophotometric, ﬁrst derivative and HPTLC methods
for quantifying Oﬂoxacin and Nitazoxanide simultaneously in
their mixture forms. The proposed methods are simple, conve-
nient, precise, accurate, and economical than the reported
method. All chemicals and reagents used are of analytical
grade and were purchased from Merck Chemicals, India. All
dilutions were performed in standard volumetric ﬂasks. Pure
and tablet dosage form, Nitazete-O (claim: 500 mg NT and
200 mgOF) was procured from the local market (see. Fig. 1).
2. Experimental
2.1. Instrumentation and chromatographic conditions
Chromatography was performed on 10 cm · 10 cm precoated
silica gel 60 F254 HPTLC plates. The chromatographic plates
were prewashed with methanol and dried in an oven at
120 C for 2 h before use. The samples were applied onto the
plates as a band with 6 mm width using Camag 100 ll sample
syringe (Hamilton, Switzerland) with a Linomat 5 applicator
(Camag, Switzerland). Linear ascending development was car-
ried out in a twin trough glass chamber (for 10 · 10 cm). Den-
sitometric scanning was performed using Camag TLC scanner
3 in the range of 400–1500 ng/spot and operated by winCATS
software (V 1.4.2, Camag). The chromatography estimation
was performed using the following conditions: stationary
phase was precoated with silica gel 60 F254 aluminum sheets
and the mobile phase used was chloroform:carbon tetra chlo-
ride:toluene:glacial acetic acid (10:5:3:0.5 v/v). The source of
radiation was a deuterium lamp. Slit dimensions were6 mm · 0.45 mm and the scanning speed 20 mm/s. Plates were
evaluated densitometrically at 289 nm with a CAMAG Scan-
ner III, in conjunction with the winCATS software for
quantitation.
2.2. Preparation of standard and sample solution of
Nitazoxanide and Oﬂoxacin
Accurately weighed 50 mg of Nitazoxanide was taken and
transferred to a 10 ml volumetric ﬂask, dissolved in methanol
and diluted up to mark to obtain stock solution of 5000 lg/
ml. From this solution, 0.5 ml was diluted to 20 ml to get
2500 lg/ml standard Nitazoxanide solutions. Accurately about
10 mg of Oﬂoxacin was weighed and transferred to a 10 ml
amber colored volumetric ﬂask and dissolved in methanol
and volume was made up to mark to get stock solution of
1000 lg/ml. From this solution, 0.75 ml was further diluted
to 10 ml to get 75 lg/ml standard Oﬂoxacin solutions. Accu-
rately weighed 5 mg of rosiglitazone maleate was taken in a
25.0 ml volumetric ﬂask. This was dissolved in minimum quan-
tity of acetonitrile and diluted up to the mark with acetonitrile
to get 500 lg/ml of rosiglitazone maleate. Rosiglitazone male-
ate was used as an internal standard.
Twenty Nitazete-O tablets were weighed and ﬁnely pow-
dered. An amount of the tablet powder equivalent to 500 mg
Nitazoxanide and 200 mg of Oﬂoxacin was weighed and trans-
ferred into a 100.0 ml standard volumetric ﬂask. Sixty millili-
ters of methanol was added to the ﬂask and was sonicated
for 30 min. The solution was then cooled to room temperature
and diluted up to the mark with methanol. The resultant solu-
tion was ﬁltered through Whatman Grade I ﬁlter paper. The
ﬁltrate was used as sample solution.
2.3. UV–vis spectrophotometric
UV–vis spectrophotometer 1601 (Shimadzu, Japan) with spec-
tral bandwidth of 2 nm and 10 mm matched quartz cells was
used. By appropriate dilution of two standard drug solutions
with methanol, solutions containing 50 lg/ml of Nitazoxanide
S64 S. Sharma et al.and 20 lg/ml of Oﬂoxacin were scanned separately in the
range of 200–400 nm to determine the wavelength of maximum
absorption for both drugs. They were scanned in the wave-
length range of 400–200 nm and the overlain spectrum was
obtained. Two wavelengths 221.8 nm (kmax of Nitazoxanide)
and 244.3 nm (kmax of Oﬂoxacin) were selected for the forma-
tion of simultaneous equation. The calibration curves were
found to be linear in the concentration range of 5–25 lg/ml,
for each drug. The absorptivity coefﬁcients of each drug at
both wavelengths were determined. The concentration of two
drugs in the mixture was calculated using equations (Beckett
and Stanlake, 1997).
CNitazoxanide ¼ A2ay1  A1ay2=ax2ay1  ax1ay2 ð1Þ
COfloxacin ¼ A1ax2  A2ax2=ax2ay1  ax1ay2 ð2Þ
where, A1 and A2 are absorbance of mixture at 221.8 nm
and 244.3 nm; ax1 and ax2, absorptivities of Nitazoxanide
at 221.8 nm and 244.3 nm, respectively; ay1 and ay2 absorptiv-
ities of Oﬂoxacin at 266.8 nm and 244.3 nm, respectively.
CNitazoxanide and COﬂoxacin are concentration of Nitazoxanide
and Oﬂoxacin in mixture. The absorptivities reported are the
mean of six independent determinations.
In First order derivative spectroscopy method Nitazoxa-
nide (50 lg/ml) and Oﬂoxacin (20 lg/ml), were prepared sepa-
rately by appropriate dilution of standard stock solution and
scanned in the spectrum mode from 400 nm to 200 nm. The
absorption spectra thus obtained were derivatized from ﬁrst
to fourth order. First order derivative spectra were selected
for the analysis of both drugs. From the overlain spectra of
both drugs wavelengths selected for quantitation were
263.6 nm for Nitazoxanide (zero cross for Oﬂoxacin) and
269.2 nm for Oﬂoxacin (zero cross for Nitazoxanide). The cal-
ibration curves for Nitazoxanide and Oﬂoxacin were plotted in
the concentration range of 5–50 lg/ml at wavelength 263.6 nm
and 269.2 nm, respectively.
The methods were validated with respect to linearity, accu-
racy, precision and selectivity (ICH,1996). To ascertain the
accuracy of the proposedmethods, recovery studieswere carried
out by standard addition method at three different levels 80%,
100% and 120%. The mean percent recovery for Nitazoxanide
andOﬂoxacin by all the threemethods was found in the range of
97.66–101.11%. The linearity of measurement was evaluated by




Precision (a) Intra-day 2.65 1.63
(b) Inter-day 1.64 0.48
RF (SD) –– ––
Linearity and range (ng/spot) –– ––
Linearity detection (ng/spot) –– ––
Limit of quantiﬁcation (ng/spot) –– ––




a SD = Standard deviation.Nitazoxanide and Oﬂoxacin. For simultaneous equation and
area under the curvemethod, the Beer–Lambert’s concentration
range was found to be 5–25 lg/ml and for derivative spectro-
photometer 5–50 lg/ml for both Nitazoxanide and Oﬂoxacin.
The reproducibility of the proposed method was determined
by performing tablet assay at different time intervals (morning,
afternoon and evening) on same day (Intraday assay precision)
and on three different days (Interday precision). Result of intra-
day and interday precision is expressed in%RSD (Table 1). Per-
cent RSD for Intraday assay precision was found to be 0.0783
(for Nitazoxanide) and 0.1863 (for Oﬂoxacin) in simultaneous
equation method; 0.1392 (for Nitazoxanide) and 0.1174 (for
Oﬂoxacin) in ﬁrst derivative spectrophotometric method. Inter-
day assay precision was found to be 0.263 (for Nitazoxanide)
and 0.131 (for Oﬂoxacin) in simultaneous equation method;
0.029 (for Nitazoxanide) and 0.048 (for Oﬂoxacin) in ﬁrst deriv-
ative spectrophotometric method (Table 2).
3. Results and discussion
The proposed method was validated for precision, accuracy,
speciﬁcity, linearity and range, limit of detection (LOD) and
limit of quantitation (LOQ), and robustness. Validation of
the proposed method was carried out in accordance with the
International Conference on Harmonization (ICH, 1996)
guidelines. The linearity of the calibration plots was conﬁrmed
by the high value of the correlation coefﬁcients (r2 = 0.9991
for Nitazoxanide and 0.9997 for Oﬂoxacin). The assay of Nita-
zoxanide and Oﬂoxacin was found to be 99.96% and 100.11%.
From the recovery studies it was found that about 100.36%
and 100.27% of Nitazoxanide and Oﬂoxacin respectively
which indicates high accuracy of the method (Table 3). The
minimum amounts detected under the chromatographic condi-
tions used were estimated in terms of the LOD and was found
to be 5.3 and 12.32 ng band1 for Nitazoxanide and Oﬂoxacin
respectively which indicates the method has sufﬁcient sensitiv-
ity. The LOQ was determined experimentally by spotting six
replicates of each drug at the LOQ concentration. By area,
LOQ was found to be 26 and 6.5 ng band1 for Nitazoxanide
and Oﬂoxacin, respectively. Repeatability studies were per-
formed by the analysis of three different concentrations (500,
1000, 2500 ng band1) of the drug, each concentration injected
six times on the same day. Intermediate precision of the meth-
od was checked by repeating studies on three different days. Inand Oﬂoxacin.
UV method-II HPTLC
NTO OFL NTO OFL
0.681 0.317 0.451 0.654
0.954 0.215 1.45 0.974
1.21 0.62 0.154 0.654
–– –– 0.57 0.63
–– –– 400–2500 400–1200
–– –– 112 150
–– –– 164 217
99.98 100.08 99.94 99.85
0.144 0.165 5.3 6.5
0.095 0.0.81 26.00 12.32
Table 3 Results of recovery studies.
Level of recovery (%) Drug HPTLC UV-Method I UV-Method II
Recovery (%)* ±SD* Recovery (%)* ±SD* Recovery (%)* ±SD*
80 NTO 100.36 0.043 99.95 0.033 100.07 0.0321
OFL 100.27 0.154 99.97 0.0761 100.21 0.0543
100 NTO 100.01 0.049 100.04 0.0207 99.96 0.0612
OFL 99.93 0.0654 100.06 0.0381 100.09 0.0431
120 NTO 99.97 0.044 100.08 0.0549 99.90 0.0543
OFL 100.12 0.219 99.94 0.0087 99.82 0.0451
Table 2 Results of analysis of tablet formulation.
Method Tablet content Label claim (mg/tab) Amount Founda ±SDa RSD (%)a
(in mg) (In%)
UV-I NTO 500 499.974 99.994 0.041 0.18
OFL 200 199.053 99.931 0.035 0.051
UV-II NTO 500 500.03 100.05 0.143 0.217
OFL 200 199.31 99.986 0.087 0.328
HPTLC NTO 500 499.941 99.941 0.198 0.054
OFL 200 200.31 100.31 0.142 0.083
NTO=Nitazoxanide; OFL= Oﬂoxacin.
a Denotes n= 6, average of six determinations.
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titation were 221.8 nm (kmax of Nitazoxanide) and 244.3 nm
(kmax of Oﬂoxacin). In ﬁrst order derivative spectroscopy,
wavelengths selected for quantitation were 263.6 nm for Nita-
zoxanide (zero cross for Oﬂoxacin) and 269.2 nm for Oﬂoxacin
(zero cross for Nitazoxanide). For UV spectrophotometric
method, linearity was obtained in the concentration range of
5–25 lg/ml, for both drugs; with regression 0.9994 and
0.9997, intercept 0.0854 and 0.0328 and slope 0.0188 and
0.0742 for Nitazoxanide and Oﬂoxacin, respectively. For UV
Spectrophotometric method LOD for Nitazoxanide and
Oﬂoxacin was found to be 0.021 and 0.065 lg/ml respectively.
LOQ for Nitazoxanide and Oﬂoxacin was found to be 0.012
and 0.041 lg/ml respectively. These data show that microgram
quantity of both drugs can be accurately determined. Robust-
ness of the method when small changes in the mobile phase
composition (±0.1 ml for each component) were made and
the effects on the results were examined.
4. Conclusion
The proposed HPTLC method was validated as per ICH
guidelines. The standard deviation, %RSD and standard error
calculated for the method are low, indicating a high degree of
precision of the methods. The results of the recovery studies
performed show a high degree of accuracy of the proposed
methods. The proposed method is highly accurate, selective
and precise hence can be used for a routine quality-control
analysis and quantitative simultaneous determination of
Nitazoxanide and Oﬂoxacin in pharmaceutical preparations.
Moreover, the proposed method has the advantages of simplic-
ity, convenience and quantiﬁcation of Nitazoxanide and
Oﬂoxacin in combination and can be used for the assay of their
dosage form.Acknowledgements
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